Your browser doesn't support javascript.
loading
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.
Ashina, Messoud; Mitsikostas, Dimos D; Ramirez Campos, Verena; Barash, Steve; Ning, Xiaoping; Diener, Hans-Christoph.
Afiliação
  • Ashina M; Department of Neurology, Danish Headache Center, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mitsikostas DD; First Neurology Department, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Ramirez Campos V; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA.
  • Barash S; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA.
  • Ning X; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA.
  • Diener HC; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty of the University Duisburg-Essen, Essen, Germany.
Headache ; 63(10): 1351-1358, 2023.
Article em En | MEDLINE | ID: mdl-37955395
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Números Necessários para Tratar / Transtornos de Enxaqueca Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Números Necessários para Tratar / Transtornos de Enxaqueca Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article